[1] |
Jemal A,Bray F,Center MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2): 69-90.
|
[2] |
赵平,陈万青.2010 中国肿瘤登记年报[M]. 北京: 军事医学科学出版社,2011: 2.
|
[3] |
Chen W,Zheng R,Zhang S,et al. Report of incidence and mortality in China cancer registries, 2009[J]. Chin J Cancer Res,2013,25(1): 10-21.
|
[4] |
Stingl J,Caldas C.Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis[J]. Nat Rev Cancer,2007,7(10): 791-799.
|
[5] |
Lujambio A,Lowe SW.The microcosmos of cancer[J].Nature,2012,482(7385): 347-355.
|
[6] |
McAllister SS, Weinberg RA. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis[J]. Nat Cell Biol,2014,16(8): 717-727.
|
[7] |
Perrino C,Schiattarella GG,Magliulo F,et al. Cardiac side effects of chemotherapy: state of art and strategies for a correct management[J]. Curr Vasc Pharmacol,2014,12(1): 106-116.
|
[8] |
MacDonald V. Chemotherapy: managing side effects and safe handling[J]. Can Vet J,2009,50(6): 665-668.
|
[9] |
Valent P,Bonnet D,De Maria R,et al. Cancer stem cell definitions and terminology: the devil is in the details[J]. Nat Rev Cancer,2012,12(11): 767-775.
|
[10] |
Visvader JE.Cells of origin in cancer[J]. Nature,2011,469(7330): 314-322.
|
[11] |
Meacham CE,Morrison SJ. Tumour heterogeneity and cancer cell plasticity[J].Nature,2013,501(7467): 328-337.
|
[12] |
Massagué J.G1 cell-cycle control and cancer[J].Nature,2004,432(7015): 298-306.
|
[13] |
Reya T, Morrison SJ, Clarke MF,et al. Stem cells, cancer,and cancer stem cells[J].Nature,2001,414(6859): 105-111.
|
[14] |
Coussens LM,Werb Z. Inflammation and cancer[J]. Nature,2002,420(6917): 860-867.
|
[15] |
Medema JP,Vermeulen L. Microenvironmental regulation of stem cells in intestinal homeostasis and cancer[J]. Nature,2011,474(7351): 318-326.
|
[16] |
Jenq RR, van den Brink MR. Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer[J].Nat Rev Cancer,2010,10(3): 213-221.
|
[17] |
Anderson MR,Green HN. Implications of the immunological theory of cancer to multiple causes[J]. Nature,1965,208(5008): 338-339.
|
[18] |
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation[J].Cell,2011,144(5): 646-674.
|
[19] |
Vineis P, Wild CP. Global cancer patterns: causes and prevention[J].Lancet,2014,383(9916): 549-557.
|
[20] |
Finkel T,Serrano M,Blasco MA.The common biology of cancer and ageing[J].Nature,2007,448(7155): 767-774.
|
[21] |
Ribatti D.Cancer stem cells and tumor angiogenesis[J].Cancer Lett,2012,321(1): 13-17.
|
[22] |
Zhao Y, Bao Q, Renner A, et al. Cancer stem cells and angiogenesis[J].Int J Dev Biol,2011,55(4/5): 477-482.
|
[23] |
Li PW.Application of traditional Chinese patent drugs in cancer treatment[J].Zhonghua Zhong Liu Za Zhi,2011,33(5): 400.
|
[24] |
Baumann S,Fas SC,Giaisi M,et al.Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLC gamma 1- and Ca2+-dependent apoptosis[J].Blood,2008,111(4): 2354-2363.
|
[25] |
Bergh J, Mariani G, Cardoso F, et al. Clinical and pharmacokinetic study of sunitinib and docetaxel in women with advanced breast cancer[J].Breast,2012,21(4): 507-513.
|
[26] |
Zhang N, Kong X,Yan S,et al.Huaier aqueous extract inhibits proliferation of breast cancer cells by inducing apoptosis[J].Cancer Sci,2010,101(11): 2375-2383.
|
[27] |
Ferrara N,Kerbel RS.Angiogenesis as a therapeutic target[J].Nature,2005,438(7070): 967-974.
|
[28] |
胡保全,唐鹏,齐晓伟,等. 槐耳清膏对乳腺癌细胞系SUM-159 细胞干性特征的影响[J]. 第三军医大学学报,2013,35(11): 1107-1110.
|
[29] |
Topalian SL,Weiner GJ,Pardoll DM. Cancer immunotherapy comes of age[J].J Clin Oncol,2011,29(36): 4828-4836.
|
[30] |
Dewan MZ,Terunuma H, Takada M,et al.Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo[J].Breast Cancer Res Treat,2007,104(3): 267-275.
|
[31] |
汤钊猷. 癌转移研究的几个重要问题[J].中华消化外科杂志,2014,13(3): 161-164.
|